We are live on ! Find out more
NVO

Novo Nordisk

411 hedge funds and large institutions have $5.8B invested in Novo Nordisk in 2013 Q2 according to their latest regulatory filings, with 411 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

111% more call options, than puts

Call options by funds: $89.1M | Put options by funds: $42.3M

84.64% more ownership

Funds ownership: 0%84.64% (+85%)

Holders
411
Holders Change
+411
Holders Change %
% of All Funds
13.41%
Holding in Top 10
12
Holding in Top 10 Change
+12
Holding in Top 10 Change %
% of All Funds
0.39%
New
411
Increased
Reduced
Closed
Calls
$89.1M
Puts
$42.3M
Net Calls
+$46.8M
Net Calls Change
+$46.8M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

NVO Hedge Fund Activity: Q2 2013 in Review

411 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Novo Nordisk (NVO) for Q2 2013, worth a combined $5.8B.

Buyers outnumbered sellers: 411 funds opened new NVO positions and 0 closed out — a net gain of 411 holders — while 0 added to existing stakes and 0 trimmed.

  • 411 institutional investors held Novo Nordisk (NVO) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $5.8B of Novo Nordisk stock for Q2 2013.
  • 411 funds opened new Novo Nordisk positions in Q2 2013 and 0 closed out, a net change of +411 holders.

Based on aggregated 13F filings for Q2 2013.